Clinical Trial Update: Evaluation of the Efficacy of CANNABIDIOL on the Pruritus in Children With Hereditary Epidermolysis Bullosa [Phase 2]

View source ↗

Summary

Phase 2 trial evaluated cannabidiol for pruritus in children with hereditary epidermolysis bullosa; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Epidermolysis Bullosa

Drugs mentioned

• Cannabidiol (cannabidiol)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Hereditary Epidermolysis Bullosa | Phase 2 | Status: COMPLETED